Ninety-Day Mortality as a Reporting Parameter for High-Grade Serous Ovarian Cancer Cytoreduction Surgery.
作者： Ryan J. Spencer , Kari E. Hacker , Jennifer J. Griggs , Laurel W. Rice , R. Kevin Reynolds
DOI: 10.1097/AOG.0000000000002140
关键词:
摘要: Objective To evaluate the utility of using 90-day as an adjunct to 30-day mortality rates after surgical cytoreduction for serous ovarian cancer and compare them across hospitals differing case volumes over time. Methods We performed a retrospective cohort study National Cancer Database women undergoing cytoreductive surgery high-grade carcinoma between 2004 2012. The primary outcome was rate by hospital volume. secondary performance rankings based on 30- rates. Hospitals were categorized cases per year low volume (10 or fewer), intermediate (11-20), high (21-30), ultra-high (31 more). Results A total 24,827 from 602 included. Overall 2.1% (95% CI 1.95-2.3) compared with 5.1% 4.8-5.4%, P Conclusion Compared low-volume centers, ultra-high-volume centers are associated significantly lower risk-adjusted mortality. is double that may be better metric assessing initial quality care patients cancer.
sci-hub.se 参考文章(22)
Karl Y. Bilimoria, Andrew K. Stewart, David P. Winchester, Clifford Y. Ko, The National Cancer Data Base: A Powerful Initiative to Improve Cancer Care in the United States Annals of Surgical Oncology. ,vol. 15, pp. 683- 690 ,(2008) , 10.1245/S10434-007-9747-3
Robert E. Bristow, Bryan E. Palis, Dennis S. Chi, William A. Cliby, The National Cancer Database report on advanced-stage epithelial ovarian cancer: Impact of hospital surgical case volume on overall survival and surgical treatment paradigm Gynecologic Oncology. ,vol. 118, pp. 262- 267 ,(2010) , 10.1016/J.YGYNO.2010.05.025
E. Onukwugha, J. Bergtold, R. Jain, A Primer on Marginal Effects—Part II: Health Services Research Applications PharmacoEconomics. ,vol. 33, pp. 97- 103 ,(2015) , 10.1007/S40273-014-0224-0
Ayesha S. Bryant, Kyle Rudemiller, Robert J. Cerfolio, The 30- Versus 90-Day Operative Mortality After Pulmonary Resection The Annals of Thoracic Surgery. ,vol. 89, pp. 1717- 1723 ,(2010) , 10.1016/J.ATHORACSUR.2010.01.069
John D. Birkmeyer, Andrea E. Siewers, Emily V.A. Finlayson, Therese A. Stukel, F. Lee Lucas, Ida Batista, H. Gilbert Welch, David E. Wennberg, Hospital Volume and Surgical Mortality in the United States The New England Journal of Medicine. ,vol. 346, pp. 1128- 1137 ,(2002) , 10.1056/NEJMSA012337
Haejin In, Bryan E. Palis, Ryan P. Merkow, Mitchell C. Posner, Mark K. Ferguson, David P. Winchester, Christopher M. Pezzi, Doubling of 30-Day Mortality by 90 Days After Esophagectomy: A Critical Measure of Outcomes for Quality Improvement Annals of Surgery. ,vol. 263, pp. 286- 291 ,(2016) , 10.1097/SLA.0000000000001215
Robert E. Bristow, Antonio Santillan, Teresa P. Diaz-Montes, Ginger J. Gardner, Robert L. Giuntoli, Benjamin C. Meisner, Kevin D. Frick, Deborah K. Armstrong, Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis. Cancer. ,vol. 109, pp. 1513- 1522 ,(2007) , 10.1002/CNCR.22561
R. A. M. Damhuis, B. P. L. Wijnhoven, P. W. Plaisier, W. J. Kirkels, R. Kranse, J. J. van Lanschot, Comparison of 30-day, 90-day and in-hospital postoperative mortality for eight different cancer types. British Journal of Surgery. ,vol. 99, pp. 1149- 1154 ,(2012) , 10.1002/BJS.8813
Richard S. Swanson, Christopher M. Pezzi, Katherine Mallin, Ashley M. Loomis, David P. Winchester, The 90-Day Mortality After Pancreatectomy for Cancer Is Double the 30-Day Mortality: More than 20,000 Resections From the National Cancer Data Base Annals of Surgical Oncology. ,vol. 21, pp. 4059- 4067 ,(2014) , 10.1245/S10434-014-4036-4
Deborah Schrag, Craig Earle, Feng Xu, Katherine S. Panageas, K. Robin Yabroff, Robert E. Bristow, Edward L. Trimble, Joan L. Warren, Associations Between Hospital and Surgeon Procedure Volumes and Patient Outcomes After Ovarian Cancer Resection Journal of the National Cancer Institute. ,vol. 98, pp. 163- 171 ,(2006) , 10.1093/JNCI/DJJ018